Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ceres Nanosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ceres Nanosciences

Ceres Nanosciences

Series A

and commercialization of innovative diagnostic tools.

HQ
Manassas, VA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Ceres Nanosciences, founded in Manassas, Virginia, is a privately held life sciences company dedicated to the research, development, and commercialization of innovative diagnostic tools. The company's core mission is to enhance diagnostic capabilities through advanced nanotechnology, aiming to improve healthcare outcomes globally. Ceres Nanosciences offers a range of products focused on the early detection and monitoring of diseases, leveraging their proprietary Nanotrap® technology to capture and concentrate low-abundance biomarkers from biological samples.

Ceres Nanosciences has garnered attention from notable investors and partners within the biotechnology and healthcare sectors. The company has achieved significant milestones, including securing funding for research and development and forming strategic partnerships to expand the application of their diagnostic tools. Their impact is evident in the improved sensitivity and accuracy of diagnostic tests, contributing to earlier disease detection and better patient management.

Ceres Nanosciences - Similar Companies

Nanoscope Technologies logo

Nanoscope Technologies

Nanopath logo

Nanopath

nanopathdx.com

NanoCytomics logo

NanoCytomics

nano-cytomics.com

NanoHybrids logo

NanoHybrids

nanohybrids.net

NanoDx logo

NanoDx

NanoEngineering logo

NanoEngineering

Nanotools Bioscience logo

Nanotools Bioscience

nanotoolsbio.com

Nanomatronix logo

Nanomatronix

nanomatronix.com

NanoMosaic logo

NanoMosaic

Nanospectra Biosciences logo

Nanospectra Biosciences

nanospectra.com

Cerora logo

Cerora

cerora.com

Nano Cures logo

Nano Cures

nanocures.com

BioNanovations logo

BioNanovations

Scintillation Nanotechnologies logo

Scintillation Nanotechnologies

sntnano.com

NanoMedTrix logo

NanoMedTrix

Ceres Nanosciences - Quick Facts

Who are Ceres Nanosciences' competitors?

Companies similar to Ceres Nanosciences include Nanoscope Technologies, Nanopath, NanoCytomics and NanoHybrids.

When was Ceres Nanosciences founded?

Ceres Nanosciences was founded in 2008.

Where is Ceres Nanosciences' headquarters located?

Ceres Nanosciences' headquarters is located in Manassas, VA, US.

When was Ceres Nanosciences' last funding round?

Ceres Nanosciences' most recent funding round was for $5M (USD) in September 2022.

How much has Ceres Nanosciences raised to-date?

As of Sep 9, 2022, Ceres Nanosciences has raised a total of $24.5M (USD).

How many employees does Ceres Nanosciences have?

Ceres Nanosciences has 45 employees as of Feb 5, 2024.

Ceres Nanosciences - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Nanotechnology
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Tools
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified